Associated Papers
Neuroendocrine neoplasms as a lynch syndrome manifestation: a case report and comprehensive literature review.
Bernal Zárate MP et al.
Frontiers in Endocrinology, 2025
Characteristics of Cancer in Subjects Carrying Lynch Syndrome-Associated Gene Variants in Taiwanese Population: A Hospital-Based Study in Taiwan.
Chen YP et al.
Cancers, 2024
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors.
Ali-Fehmi R et al.
Jco Precision Oncology, 2024
Phase separation as a possible mechanism for dosage sensitivity.
Yang L et al.
Genome Biology, 2024
38225666 (PubMed )
Supplement: 13059_2023_3128_MOESM3_ESM.xlsx › NMD-escaping_mutations
The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K et al.
Endocrine Journal, 2023
Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series.
Kidambi TD et al.
Familial Cancer, 2017
MSH6 mutation in a family affected by Muir-Torre syndrome.
Kacerovska D et al.
The American Journal of Dermatopathology, 2012
[Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
Kacerovská D et al.
Ceskoslovenska Patologie, 2010
An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.
Arnold A et al.
Familial Cancer, 2007
Next Generation Sequencing in Molecular Diagnosis of Lynch Syndrome - a Pilot Study Using New Stratification Criteria.
Kašubová I et al.
Acta Medica (hradec Kralove), 0
Select a paper to view details